LIPG and coronary artery disorder: Because a reduced plasma HDL‐C level is a well‐documented and modifiable risk factor for atherosclerotic diseases, including CAD and ischemic stroke, many genetic association studies have investigated the effects of common sequence variants in LIPG on HDL‐C levels and diseases related to HDL‐C levels.